guidelines:
  1: UCLA_Integrated_Staging_System_UISS_for_Renal_Cell_Carcinoma_RCC_guideline.v1
test_cases:
- id: L, T1, F1, E0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: 1|local::at0040|I|
      gt0020|ECOG Performance Status: 0|local::at0045|Asymptomatic|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0026|91.1%|
- id: L, T1,F2, E1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: 2|local::at0041|II|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: L, T1, F3, E1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0009|T1|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: L, T2, F3, E1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0010|T2|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: L, T3, F>1, E >=1
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0028|54.7%|
- id: L, T3, F3, E 0
  input:
    1:
      gt0003|Type of disease present: local::at0006|Localized|
      gt0004|Localized disease - T stage: local::at0011|T3|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0020|ECOG Performance Status: 0|local::at0045|Asymptomatic|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0027|80.4%|
- id: M, N1,M0
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0007|Metastatic disease - N stage: local::at0035|N1|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
      gt0020|ECOG Performance Status: 0|local::at0045|Asymptomatic|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0029|32%|
- id: M, N2M0,F1, E0
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 1|local::at0040|I|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
      gt0020|ECOG Performance Status: 0|local::at0045|Asymptomatic|
  expected_output:
    1:
      gt0010|Risk: local::at0022|Low|
      gt0011|Five-year disease-specific survival: local::at0029|32%|
- id: M, N2M0, F1, E1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 1|local::at0040|I|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0038|M0|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: M, N2M1, F2, E1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 2|local::at0041|II|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0039|M1|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: M, N2M1, F3
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 3|local::at0042|III|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0039|M1|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: M, N2M1, F4,E0
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 4|local::at0043|IV|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0039|M1|
      gt0020|ECOG Performance Status: 0|local::at0045|Asymptomatic|
  expected_output:
    1:
      gt0010|Risk: local::at0023|Intermediate|
      gt0011|Five-year disease-specific survival: local::at0030|19.5%|
- id: M, N2M1, F4,E1
  input:
    1:
      gt0003|Type of disease present: local::at0005|Metastatic|
      gt0005|Fuhrman nuclear grade: 4|local::at0043|IV|
      gt0007|Metastatic disease - N stage: local::at0036|N2|
      gt0008|Metastatic disease - M stage: local::at0039|M1|
      gt0020|ECOG Performance Status: 1|local::at0046|Symptomatic but completely ambulatory|
  expected_output:
    1:
      gt0010|Risk: local::at0024|High|
      gt0011|Five-year disease-specific survival: local::at0031|0%|
